Your browser doesn't support javascript.
loading
Increase in endogenous glucose production with SGLT2 inhibition is attenuated in individuals who underwent kidney transplantation and bilateral native nephrectomy.
Daniele, Giuseppe; Solis-Herrera, Carolina; Dardano, Angela; Mari, Andrea; Tura, Andrea; Giusti, Laura; Kurumthodathu, Jancy J; Campi, Beatrice; Saba, Alessandro; Bianchi, Anna Maria; Tregnaghi, Carla; Egidi, Maria Francesca; Abdul-Ghani, Muhammad; DeFronzo, Ralph; Del Prato, Stefano.
Afiliação
  • Daniele G; Department of Clinical and Experimental Medicine, Section of Metabolic Diseases and Diabetes, University of Pisa, Via Paradisa 2, 56124, Pisa, Italy.
  • Solis-Herrera C; Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Dardano A; Department of Clinical and Experimental Medicine, Section of Metabolic Diseases and Diabetes, University of Pisa, Via Paradisa 2, 56124, Pisa, Italy.
  • Mari A; Metabolic Unit, CNR Institute of Neuroscience, Padova, Italy.
  • Tura A; Metabolic Unit, CNR Institute of Neuroscience, Padova, Italy.
  • Giusti L; Department of Clinical and Experimental Medicine, Section of Metabolic Diseases and Diabetes, University of Pisa, Via Paradisa 2, 56124, Pisa, Italy.
  • Kurumthodathu JJ; Department of Clinical and Experimental Medicine, Section of Metabolic Diseases and Diabetes, University of Pisa, Via Paradisa 2, 56124, Pisa, Italy.
  • Campi B; Department of Clinical and Experimental Medicine, Section of Metabolic Diseases and Diabetes, University of Pisa, Via Paradisa 2, 56124, Pisa, Italy.
  • Saba A; Department of Clinical and Experimental Medicine, Section of Metabolic Diseases and Diabetes, University of Pisa, Via Paradisa 2, 56124, Pisa, Italy.
  • Bianchi AM; Department of Clinical and Experimental Medicine, Section of Metabolic Diseases and Diabetes, University of Pisa, Via Paradisa 2, 56124, Pisa, Italy.
  • Tregnaghi C; Department of Clinical and Experimental Medicine, Section of Metabolic Diseases and Diabetes, University of Pisa, Via Paradisa 2, 56124, Pisa, Italy.
  • Egidi MF; Department of Clinical and Experimental Medicine, Section of Metabolic Diseases and Diabetes, University of Pisa, Via Paradisa 2, 56124, Pisa, Italy.
  • Abdul-Ghani M; Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • DeFronzo R; Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Del Prato S; Department of Clinical and Experimental Medicine, Section of Metabolic Diseases and Diabetes, University of Pisa, Via Paradisa 2, 56124, Pisa, Italy. stefano.delprato@med.unipi.it.
Diabetologia ; 63(11): 2423-2433, 2020 11.
Article em En | MEDLINE | ID: mdl-32827269
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transportador 2 de Glucose-Sódio / Glucose Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Aged / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transportador 2 de Glucose-Sódio / Glucose Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Aged / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article